Navigation Links
Amira Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
Date:1/11/2010

SAN DIEGO, Jan. 11 /PRNewswire/ -- Amira Pharmaceuticals, Inc., a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory disease, announced today that Robert Baltera, Chief Executive Officer, will present a company overview at the 28th Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for 2:00 p.m. PST on Thursday, January 14, at the Westin St. Francis in San Francisco, Calif. The J.P. Morgan Healthcare Conference is one of the largest and most informative healthcare investment symposiums in the industry. Over 300 public and private companies are expected to present at the conference.

About Amira

Founded in 2005 and headquartered in San Diego, Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory disease. Our discovery team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and fibrotic diseases. Amira has a partnership with GlaxoSmithKline for the development of FLAP (5-lipoxygenase activating protein) inhibitors in respiratory and cardiovascular disease.

Amira combines the rigor of a big pharmaceutical company with the ingenuity and energy of a small company, creating an environment for efficient development of novel compounds and effective pre-clinical and clinical program decisions. Its scientific founders have successfully worked together for more than a decade and were pivotal in the discovery of a number of inflammatory drugs, including Singulair®. The drug hunters at Amira are now actively leveraging their history of success to create high-value compounds for the future. For more information, visit

SOURCE Amira Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Amira Initiates Phase I Clinical Trial of Novel DP2 Antagonist
2. Amira Pharmaceuticals Hires Industry Veteran for CFO Position
3. China Yongxin Pharmaceuticals Opened Three New Stores in 2009 and Expanded Customer Base
4. China Yongxin Pharmaceuticals Projects Higher Net Income and EPS on Reduced Revenue for Full-Year 2009
5. Biostar Pharmaceuticals, Inc. to Launch Xin Aoxing Oleanolic Acid Capsules in Beijing and Shanghai
6. Arena Pharmaceuticals Announces Merck Discontinues Development of Investigational Niacin Receptor Agonist Program for Atherosclerosis
7. Poniard Pharmaceuticals Announces $6.5 Million Financing
8. Titan Pharmaceuticals to Receive $3 Million Loan
9. OncoGenex Pharmaceuticals to Host Investor Conference Call at 8:30 a.m. ET, December 21, 2009
10. Lotus Pharmaceuticals, Inc. Appoints OTC Division Head
11. Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013 On June 11, 2013 the ... a final decision memorandum concluding that FDG Position Emission ... management of anti-tumor strategy, and the agency ended the ... PET Registry (NOPR) was developed jointly by the ACR ... the Coverage with Evidence Development (CED) program to determine ...
(Date:6/17/2013)... 2013 NASA deployed an ... helps better monitor potentially harmful chemicals in the air ... was developed by Draper Laboratory , is currently ... breathe air that is processed and re-circulated within the ... the air, even in trace amounts, endangers their health. ...
(Date:6/17/2013)... (PRWEB) June 17, 2013 The Defense ... Research Technical Review at the Waterford in Springfield, Virginia ... 300 grant awardees will present technical details on their ... will cover a broad range of counter WMD areas ... Information and Network Science; (3) Science for Protection; (4) ...
(Date:6/17/2013)... /PRNewswire-iReach/ -- The latest research on stuttering is using ... the neurophysiological nature of stuttering, its connection with related ... bullying and teasing. (Photo: http://photos.prnewswire.com/prnh/20130617/CG33085 ) ... findings at the National Stuttering Association,s 2013 Research Symposium ... More than 75 speech professionals and researchers are expected ...
Breaking Biology Technology:WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 2WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 3New Monitoring System Will Better Protect NASA Astronauts on ISS 2Invitation to Register: Annual Defense Threat Reduction Agency Basic Research Technical Review 2New Research On Stuttering Jul 2-3 At Arizona Symposium 2New Research On Stuttering Jul 2-3 At Arizona Symposium 3
... KOSN ) will announce its first quarter 2008 ... The announcement of Kosan,s first quarter 2008 financial ... webcast on May 1, 2008 at 1:30,p.m. Pacific / ... by dialing 888.680.0878 (US) or 617.213.4855 (international), access,code 63268386. ...
... SAN FRANCISCO, Calif., April 24 ,Exelixis, Inc. (Nasdaq: ... and chief executive officer of Exelixis, will present at ... ET/12:40,p.m. PT on Wednesday, April 30, 2008. Dr. Scangos ... strategy., The presentation will be webcast and may ...
... HOLX ), a diversified medical technologies company ... dedicated to,serving the healthcare needs of women, today ... operating results on Thursday, May 1, 2008 at,8:00 ... will host,a conference call on Thursday, May 1, ...
Cached Biology Technology:Kosan Announces May 1, 2008 Conference Call and Webcast of First Quarter 2008 Financial Results 2Hologic, Inc. to Release Second Quarter Fiscal 2008 Operating Results Thursday, May 1st Before Market Opens 2
(Date:6/17/2013)... and algae, is a common component of sugar-free gum ... medical field it,s approved by the FDA as ... during surgery as a substance that opens the blood/brain ... Now Profs. Ehud Gazit and Daniel Segal of Tel ... the Sagol School of Neuroscience, along with their colleague ...
(Date:6/17/2013)... MD (June 17, 2013) The AGA Research Foundation ... in the future of gastroenterology with the 2013 AGA-Horizon ... Student Abstract Prizes. , "In its third year, this ... who are embarking on promising careers in basic and ... of the AGA Research Foundation. "We are extremely proud ...
(Date:6/17/2013)... declining worldwide and a major cause is a deadly ... two-year study shows they can also die from this ... carrier host that just spreads the disease. , When ... conditions, they found at least one strain of this ... a chytrid fungus, can be fatal to year-old juveniles. ...
Breaking Biology News(10 mins):Artificial sweetener a potential treatment for Parkinson's disease 2Horizon Pharma Abstract Prizes recognize promising fellows and students 2Bullfrogs may help spread deadly amphibian fungus, but also die from it 2
... Disease Control and Prevention estimates that almost 18% of ... our growing obesity "epidemic" is driven by both inadequate ... extraordinarily difficult. One area that has caught the attention ... video game playing parallel obesity rates on a population ...
... the smoking ban in restaurants, bars and nightclubs, customers ... odors and the smell of old beer, that used ... looking at how the introduction of pleasant ambient scents ... According to Dr. Hendrik Schifferstein from Delft University of ...
... May 17, 2010 Country roadways can be hazardous for ... with moose, elk and caribou in North America and Europe ... the salt pools that collect following pavement deicing. ... with males weighing up to 720 kilograms, their salt cravings ...
Cached Biology News:Rigorous study confirms video game playing increases food intake in teens 2Clubbers can smell a good nightspot 2Of moose and men 2
... Experion HighSens reagents and supplies, ... and supplies sufficient to perform high-sensitivity ... chips on the Experion automated electrophoresis ... gel, 20 microliters RNA HighSens stain, ...
...
... BIP-NC H-IPMIK-OH Lyophilized ... FROM LIGHT. HYGROSCOPIC. PACKAGED UNDER INERT GAS. ... Peptide, V5 (Cat. No. 196810) that serves ... Bax-mediated apoptosis (~200 μM). Purity: ≥97% ...
BD Falcon microtest assay plate. 1536 well 12l, black BD Optilux PS. Polystyrene, nonsterile, no lid (15/sp, 60/ca) Packaging: 15 / pack, 60 / case ...
Biology Products: